Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Feb 26, we downgraded our recommendation on Yum! Brands Inc. ( YUM - Analyst Report ) from Neutral to Underperform based on the dim outlook for Yum!’s flagship China division, which in turn, compelled the company to slash its 2013 outlook.
Why the Downgrade?
After contributing immensely to the growth of Yum! Brands in the last few years, the Yum! China division, which holds the key to the company’s overseas expansion plans, faltered in the fourth quarter of 2012 mainly due to allegations regarding the quality of chicken supplied to KFC as well as economic slowdown.
In Dec 2012, China’s state television CCTV reported that two poultry farms in the Shandong province of China that supplied chickens to KFC and competitor McDonald’s Corp. ( MCD - Analyst Report ) had fed the chickens with unapproved levels of antibiotics. The Shanghai Food and Drug Administration (SFDA) investigation followed soon after. SFDA reported that 8 out of 19 chicken batches supplied to KFC, which were sent for examination in 2010 and 2011, contained a very high amount of the antibiotic amantadine.
Though the company claimed to be concerned regarding the safety of its food products, the negative publicity led to a steep fall in the company’s sales during the last two weeks of December.
Management is unsure about how long it will take to recover sales at KFC and expects the negative sales scenario to remain unchanged in the first quarter of 2013 in China.
Further a tough year-over-year comparison and muted consumer discretionary spending in the wake of a slowdown in China added to Yum!’s woes,. Additional costs associated with the acceleration of restaurant openings are also hurting the company’s margins persistently,
Owing to the China issues, management expects mid-single digit earnings per share decline in 2013 much lower than its long-term target of at least 10% earnings per share growth. According to management, solid results from the US and YRI businesses will not be able to contain the decline in earnings per share.
Other Stocks to Consider
Some other restaurant industry stocks with a favorable Zacks Rank include AFC Enterprises Inc. ( AFCE - Snapshot Report ) and Krispy Kreme Doughnuts Inc. ( KKD - Snapshot Report ) with a Zacks Rank #2 (Buy).
Read the full Analyst Report on YUM
Read the full Analyst Report on MCD
Read the full Snapshot Report on KKD
Read the full Snapshot Report on AFCE